AVITA Medical, Inc.
RCEL
$3.87
$0.205.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.52% | 0.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.52% | 0.59% | |||
| Cost of Revenue | 22.45% | 24.25% | |||
| Gross Profit | -4.67% | -2.76% | |||
| SG&A Expenses | -1.15% | -0.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.55% | 6.97% | |||
| Operating Income | 5.74% | -18.78% | |||
| Income Before Tax | 28.41% | -19.71% | |||
| Income Tax Expenses | -50.00% | -57.89% | |||
| Earnings from Continuing Operations | 28.42% | -19.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.42% | -19.59% | |||
| EBIT | 5.74% | -18.78% | |||
| EBITDA | 6.28% | -18.41% | |||
| EPS Basic | 28.74% | -19.11% | |||
| Normalized Basic EPS | 35.18% | -18.17% | |||
| EPS Diluted | 28.74% | -19.11% | |||
| Normalized Diluted EPS | 35.18% | -18.17% | |||
| Average Basic Shares Outstanding | 0.43% | 0.41% | |||
| Average Diluted Shares Outstanding | 0.43% | 0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||